Marco is specialised in corporate law and focuses mainly on extrajudicial activity, collaborating with the firm’s M&A department.
Marco has been a member of the firm since 2024.
The firm consolidates the practice in extraordinary transactions and in advising Italian and U.S. investors
Majority stake sold in the Italian pharmaceutical company active in neurology, psychiatry, urology and diabetology
What changes from 27 September 2026 and how to prepare
The deal allows Impresoft to focus on proprietary software, digital transformation and AI, while highlighting 4ward’s industrial f ...
The transaction completes the acquisition process launched in 2024